The family Chlamydiaceae contains two genera and nine species. Rapid and easy identification of these species is essential for taxonomic, epidemiological and clinical determinations. Currently, DNA sequence analysis is the only accepted method that decisively distinguishes all nine species. In this study, a simple and rapid PCR-RFLP procedure was developed b y which laboratorycultured chlamydial specimens could be identified. To accomplish this, conserved oligonucleotide primers and restriction sites were deduced from 165 and 235 rRNA sequence data from >50 chlamydial strains representing all nine species. DNA from 25 previously characterized chlamydial strains were tested with these primers and restriction enzymes. All nine chlamydial species were reliably distinguished in the tests. The procedure was optimized by adjusting the annealing temperature using both a standard and a heat-activated DNA polymerase to reduce mismatch PCR amplification of mycoplasmas and other bacteria. The result was that a PCR method for species identification of chlamydial isolates and for distinguishing mycoplasmas and chlamydiae was created. This method can be used to rapidly identify known species of the f am i I y Chlamydiaceae .
INTRODUCTION
The members of the order Chlamydiales are obligately intracellular bacteria that are proven or suspected pathogens of vertebrates. They cause reproductive, respiratory, cardiovascular, gastrointestinal or systemic disease, as well as conjunctivitis, arthritis and encephalitis (Birtles et al., 1997; Everett & Andersen, 2997; Kahane et al., 1996 Kahane et al., , 1998 Lieberman et al., 1997) . Recent reclassification of Chlamydiales identified four families : Parachlamydiaceae, Simkaniaceae, Waddliaceae and Chlamydiaceae (Everett et al., 1999 ; Rurangirwa et al., 1999) . In the reclassification by Everett et al. (1999) , more than 60 Chlamydiaceae strains belonging to Chlamydia trachomatis, Chlamydia psittaci, Chlamydia pneumoniae and Chlamydia pecorum were regrouped into two genera and nine species based on differences in phenotype, 16s rRNA and 23s rRNA. All species of Chlamydiaceae are recognized by monoclonal antibodies (mAbs) that detect the LPS trisaccharide epitope &do-(2 -+ 8)-aKdo-(2 + 4)-aKdo (Lobau et al., 1995) , and under natural conditions each of the species has a relatively limited host range and a relatively limited disease range. Because many animals are host to more than one chlamydial species, a simple technique that distinguishes each Chlamydiaceae species is needed for taxonomic, epidemiological and pathological studies and for improved diagnostic capability.
Efforts to develop routine species identification of chlamydiae have been ongoing since the early days of chlamydial research. Early methods relied on presumed tissue or host affinities, presumed unique epidemiology, or on specific serology, all characteristics of host response to chlamydiae. In the mid-l960s, phenotypic traits of specific chlamydial strains were identified : glycogen accumulation and sulfadiazine sensitivity (Gordon & Quan, 1965; Lin & Moulder, 1966) . These characteristics and inclusion morphology became the basis for the description and differentiation of C. trachomatis and C. psittaci species (Page, 1968 (Cox et al., 1988; Fukushi & Hirai, 1989 Grayston et al., 1989) . Recent availability of 16s and 23s rRNA sequence data has made it possible not only to classify all currently known Chlamydiaceae strains into nine species, but also to use 'signature sequences' for rapid identification of species using PCR and DNA sequencing (Everett et al., 1999) . Methods other than sequencing, however, are needed for identification of species because DNA sequencing is limited to specialized laboratories. Detection of many strains, groups of strains and species has been possible using mAbs, PCR, PCR-RFLP or DNA hybridization procedures (e.g. Andersen, 1991; Black, 1997; Kaltenbock et al., 1997; Morre et al., 1998; Sayada et al., 1995; Vretou et al., 1996; Wang et al., 1985) . However, these assays were not designed for speciationper se, so when a test fails to identify an isolate, additional effort must be invested. C . trachomatis and C. pneumoniae can be identified with commercially available mAbs. Species identification of C. trachomatis may also use mAbs that recognize a linear, variable-segment-IV epitope in the major outer-membrane protein (MOMP) (Batteiger et al., 1996) . However, the epitope recognized by these mAbs is also present in the MOMP of Chlamydia muridarum and Chlamydia suis (Everett et al., 1999) . With the change in classification, these mAbs are no longer species-specific but are, instead, genus-specific. Other mAbs previously characterized as being genus-specific must now be described as family-specific (Everett et al., 1999) . These mAbs recognize an LPS epitope in all of the species mentioned above and also in species belonging to the new genus Chlamydophila, which includes C. pecorum, C. pneumoniae, C . psittaci, Chlamydophila abortus, Chlamydophila caviae and Chlamydophila felis. DNA-based tests for chlamydiae generally target ompA, plasmid or rDNA. Nested PCR and PCR-RFLP methods have been developed to identify two to four chlamydial species (Holland et al., 1990; Kaltenbock et al., 1997; Meijer et al., 1997; Messmer et al., 1997; Tong & Sillis, 1993) . Examination of > 50 complete ompA sequences, however, indicates that nested PCR procedures cannot satisfactorily be expanded to distinguish all nine species because of the excess diversity of this gene. PCR-RFLP targeting of the rRNA operon (Meijer et al., 1997) has differentiated four chlamydial species with sub-groups in both C. trachomatis and C. psittaci. The primers that are used in that test generate a 800 bp PCR product spanning the 16s-23s ribosomal intergenic spacer. This 800 bp segment has too many restriction sites for identification of nine species. Meijer's 23s primer also has a 2-4 base mismatch with chlamydial 23s rRNA genes, which reduces both sensitivity and specificity. The rRNA operon, particularly the 16s-23s intergenic spacer, is an appropriate target for PCR-RFLP identification of species of Chlamydiaceae because it is a phylogenetic marker for the nine chlamydial species and contains conserved sequence interspersed with species-specific segments (Everett & Andersen, 1997; Everett et al., 1999) . In the present report, rDNA sequences from over 50 Chlamydiaceae strains representing all nine species were used as a basis to design PCR primers and to select enzymes for a PCR-RFLP method of identification that would distinguish the nine chlamydial species. Sizes of the PCR-RFLP fragments were consistent with reported DNA sequences. Comparative amplification using an alternative DNA polymerase made it possible to also detect mycoplasmas which may contaminate host-cell cultures or chlamydial preparations. This PCR-RFLP identification method has taxonomic, epidemiological and clinical value. (Andersen, 1991) (Sambrook et al., 1989) . PCR conditions. Primers 16SF2 (5' CCGCCCGTCACAT-CATGG 3') and 23R (5' TACTAAGATGTTTCAGTTC 3') were selected based on their conservation among all known Chlamydiaceae strains and on taxon-specific sequence variation within the predicted PCR amplicon (Everett & Andersen, 1997) . Primer 16SF2 was located at approximately nucleotide position 1400 in the chlamydial 16s rRNA gene; primer 23R was located at approximately nucleotide position 200 in the chlamydial 23s rRNA gene (Everett & Andersen, 1997) . Primer 23R had a 3 base mismatch with the Simkania sequence. These primers were used to produce PCR amplicons using 0.25 pg of each DNA template. Templates were amplified in a GeneAmp PCR System 9600 thermocycler using PCR Core Reagents, AmpliTaq DNA polymerase and/or AmpliTaq Gold DNA polymerase (Perkin-Elmer). Reaction mixes were prepared on ice, and each 50 pl mixture consisted of 1 x GeneAmp 1997). PCR amplicons for restriction analysis were produced using AmpliTaq DNA polymerase and 35 cycles of amplification: 25 s at 94 "C, 15 s at 50 "C, and 30 s at 72 "C, followed by incubation for 5 min at 72 "C. The specificity of the Ghlamydial primers was tested using both AmpliTaq DNA polymerase and Ampli Taq Gold DNA polymerase. Optimal annealing specificity was determined using seven duplicate sets of template and annealing temperatures of 50,52,54,56, 60, 64 or 66 "C. Several sets were also tested with higher annealing temperatures. PCR cycling using both enzymes was done simultaneously at each temperature, except that AmpliTaq Gold cycling was directly preceded by a 5 min incubation at 94 "C. A modified three-stage PCR cycling procedure was also developed that reduced the amplification of non-chlamydia1 PCR product but not the amount of chlamydia1 product. This modified procedure took advantage of improved techniques for using AmpliTaq Gold (Perkin-Elmer technical bulletin 77 160 1-001, 1997). The three-stage procedure consisted of a pre-cycling 10 min enzyme activation stage at 95 "C, a 10-cycle amplification stage using 54 "C annealing, and a 30-cycle amplification stage using 52 "C annealing. Optimization of PCR amplification conditions for comparison of chlamydial and mycoplasma amplicon production was carried out in 1.5% agarose gels and with 1 kb DNA Ladder (Gibco Life Technology). DNA bands were visualized using ethidium bromide.
METHODS

RESULTS
PCR and restriction analysis of 25 Chlamydiaceae strains
Sequence analysis predicted that primers 16SF2 and 23R would produce a PCR amplicon with restriction endonuclease sites that would distinguish chlamydial species by PCR-RFLP (Table 2 ). Using these primers and an annealing temperature of 50 "C, AmpliTaq DNA polymerase produced a single amplicon from all of the Chlamydiaceae. The size of the PCR product was 600 bp, using template from two strains of Chlamydia muridarum and three strains each of Chlamydia suis and Chlamydia trachomatis. A 585 bp PCR product was produced from Chlamydophila caviae, three strains each of Chlamydophila abortus, Chlamydophila felis, Chlamydophila pecorum and Chlamydophila pneumoniae, and four strains of Chlamydophila psittaci. These conditions were also used to amplify PCR product from three control-DNA templates : Legionella pneumophila, Simkania and a cloned rRNA segment of Mycoplasma orale. Although the Simkania products were predicted to be 65 bases longer than the Chlamydia products, all of the products examined by electrophoresis appeared to be approximately the same size, except that multiple bands were produced from the plasmid clone of M . orale and from L. pneumophila (not shown).
Restriction analysis of 24 of the 25 Chlamydiaceae PCR products using AciI, BclI, BfaI, HpaI, SfcI, DdeI and RsaI resulted in fragment sizes that were fully consistent with fragment sizes predicted by sequence analysis (Fig. 1) . Chlamydia1 restriction fragments could be readily distinguished from M . orale and L. pneumophila fragments by size. Extra fragments in Simkania and C. pneumoniae N16 were not fully consistent with sequence predictions (Fig. 1, Table 2 ). Optimization was required before the N16 bands could be resolved (see below). Examination of Table 2 suggested that extra Simkania fragments might be products from C. trachomatis L2/434/BU. To test this, the Simkania preparation and a different preparation of Simkania DNA were PCR amplified using AmpliTaq and also using AmpliTaq Gold. When AmpliTaq was used, both templates produced PCR products, but the products differed in size: the Simkania preparation used in Fig. 1 generated a product that was identical in size to chlamydial products; the new Simkania preparation generated a distinctly larger product (not shown). Sequence analysis of the AmpliTaq products confirmed that the apparent Simkania PCR product in Fig. 1 actually derived from contaminating C. trachomatis L2/434/BU template. This template was preferentially amplified over the Simkania template because the primers were considerably more specific for L2/434/BU. Sequence analysis of the L2/434/BU product was unambiguous. Sequence analysis of Ampli Taq mismatch-amplified PCR product from the uncontaminated Simkania preparation was also unambiguous, matching sequence data previously obtained for Simkania. When AmpliTaq Gold was used, the new Simkania preparation produced no PCR product at all, indicating that this enzyme improved the specificity of the amplification (Fig. 2) .
Increasing specificity to reduce amplification of mycoplasmas
DNA from the C. pneumoniae N 16 specimen produced a mixture of PCR-RFLP fragments, some predicted and some not predicted by rDNA sequence analysis (Fig. 1, Table 2 ). N16 fragment sizes were predicted to be nearly identical to those for other strains of C. pneumoniae (Table 2 ). Because the strain was prepared in cell culture, contamination of the sample with mycoplasmas was suspected. To determine if mycoplasmas could be a problem for chlamydial PCR-RFLP analysis, 10 Mollicutes template DNAs were obtained for PCR specificity studies : nine field isolates from the family Mycoplasmatales and one from Acholeplasmatales. A positive control was prepared from a pellet of C. psittaci-NJl-infected Vero cells and included. DNA from L. pneumophila and the new preparation of Simkania were also used (Fig. 2) . To enhance chlamydial template specificity, two method changes were used: first a hot-start amplification technique (Ampli Taq Gold) vs the standard amplification technique (Ampli Taq), and then also changes in annealing temperature (Fig. 2) . With AmpliTaq, Acholeplasma laidlawii produced little or no PCR product at any annealing temperature. At the highest possible annealing temperature (72 "C, because PCR extension took place at 72 "C), neither chlamydial nor mycoplasma template generated PCR products. Annealing temperatures of 64 "C and 62 "C produced non-specific amplicons of many sizes from most templates (not shown). With annealing of 60 "C (not shown) and 56 "C (Fig. 2) , an approximately 600 bp product was amplified from all chlamydial and non-chlamydia1 templates except A. laidlawii and two Mycoplasmatales templates ; low molecular mass PCR artifacts were apparent. The low molecular mass artifacts were not present with 54 "C annealing. With 52 "C and 50 "C annealing, all chlamydiae and Mycoplasmatales yielded single-band PCR products with Ampli Taq, although the amount of Mycoplasma mycoides and Mycoplasma arginini products were somewhat reduced at 52 "C.
In contrast, with AmpliTaq Gold and annealing at 52 "C, only 2 mycoplasmas were amplified (Fig. 2,  Table 3 ). Chlamydia1 DNA was amplified using 5&56 "C annealing temperatures and PCR artifacts were not generated. With 3 54 "C annealing, mycoplasma PCR products were barely detectable ; however, chlamydial and L. pneumophila PCR products were still readily apparent (Fig. 2, Table 3 ). The L. pneumophila amplification suggested that the L. pneumophila sequence had significant homology with both of the chlamydial primers. This homology was confirmed by sequence analysis (Table 3) . Because specificity was improved with use of AmpliTaq Gold and 52 "C and 54 "C annealing (Fig.  2) , a modified three-stage PCR cycling procedure was used to more specifically amplify C. pneumoniae N16 template so that it could be re-examined using PCR-RFLP. This procedure was designed to improve specificity for N16 without a quantitative reduction in product. The amount of improvement in N16 amplification, relative to apparent N16 fragments in Fig. 1 , could be readily assessed by electrophoresis of AciI fragments. AciI was predicted to cut N 16 PCR product into three fragments, each approximately 200 bp long ( Table 2 ). The 200 bp chlamydial AciI fragments stained intensely with ethidium bromide when the three-stage N 16 amplicon was used, but an uncleaved 650 bp band was still evident (Fig. 3) . In Fig. 1,200 bp AciI products had been almost undetectable. In Fig. 1 , four N16 bands had been distinctly inconsistent with N16 sequence data (Table 2) : the 650 bp AciI band, 500 bp DdeI band, 600 bp HpaI band and 500 bp RsaI band. With the three-stage N16 product, the intensities of these bands were greatly reduced (Fig. 3) . In addition, a 430 bp BfaI band showed itself to be a doublet of N16 and a non-chlamydia1 fragment, indicating that a BfaI site was conserved in both the chlamydial and the non-chlamydia1 products. Direct DNA sequence analysis of the uncleaved 650 bp Chlamydiaceae speciation Fig. 2 . Control of mismatch PCR amplification. A pure culture o f Simkania was used for this analysis. Identical template sets were PCR amplified, as shown, at various annealing temperatures using either AmpliTaq Gold (immediately preceded by a 5 min activation o f AmpliTaq Gold at 94 "C) or AmpliTaq. Lanes-5, Simkania; L, L. pneumophila; Chlamydiae: 1, NJI whole infected-cell nucleic acid preparation with RNase added t o the PCR amplification mix; 2, NJ1 whole infected-cell RNA and DNA; 3, NJ1 whole infected-cell DNA. Mollicutes: 1, Mycoplasma pullorum; 2, Mycoplasma mycoides; 3, Mycoplasma bovirhinis; 4, Mycoplasma bovigenitalium ; 5, Mycoplasma gallinaceum; 6, Mycoplasma arginini; 7, Mycoplasma bovis; 8, Mycoplasma californicum; 9, Mycoplasma ovipneumoniae; and 10, Acholeplasma laidlawii.
Fig. 7. PCR-RFLP of 25
Chlamydiaceae strains distinguishes nine species, using AmpliTaq and 50 "C annealing. Three nonChlamydiaceae templates were also used. Amplicons were generated with primers 16SF2 and 23R. Restriction enzymes were selected on the basis of predicted fragment sizes ( Table 2 ). The Simkania preparation in this analysis contained a small amount of C. trachomatis L2/434/BU template. Determined in this study Table 2 and with the intensity of predicted N16 fragments in Fig. 1 indicated that the proportion of N16-M. hyorhinis fragments increased with this procedure.
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AciI PCR product from N16 unambiguously showed that the non-chlamydia1 template in this specimen was Mycoplasma hyorhinis. Mapping of a 16SF2/23R contig formed from previously reported M . hyorhinis sequences (GenBank accession nos X68421 and X58555) showed that M . hyorhinis had a 1 base mismatch with each chlamydia1 primer and that the predicted M . hyorhinis RFLP fragments could account for observed non-N16 fragments in the N16 lanes of Figs 1 and 3 .
DISCUSSION
This study provided a PCR-RFLP method that can be used as a rapid, specific and inexpensive procedure for speciating Chlamydiaceae isolates. The method uses primer 16SF2, primer 23R and restriction enzymes AciI, BcZI, BfaI, DdeI, HpaI, RsaI and SfcI, selected on the basis of rDNA sequence analysis of >50 chlamydial strains. The primers generated 600 bp amplicons from Chlamydia templates and 585 bp amplicons from Chlamydophila templates. Species-specific RFLP fragment sizes were correctly predicted by sequence analysis (Fig. 1, Table 2 ). Some diversity was evident in the fragment sizes produced by C. suis templates, consistent with the substantial sequence diversity in this species (Everett & Andersen, 1997 Ch Ian i jdiaceae speciation Gold DNA polymerase, which is heat activated, preferentially amplified chlamydial template because the primers matched it exactly. Mycoplasmas from natural sources may be cultured along with chlamydiae when new isolations are made, so the discrimination provided by these enzymes enables chlamydiologists to determine whether mycoplasmas are present in new isolates while using a single test method and primer set.
Primers and restriction enzymes in this study were selected after a comprehensive comparison of sequence data (Everett & Andersen, 1997) . Primers were chosen that produced a relatively short PCR amplicon, improving the probability that amplification would be successful from even old or damaged template. A search of the GenBank database using BLAST in January 1998 showed that the 16SF2 primer matched 16s rRNA sequences from 59 chlamydial strains, several strains in the order Verruconzicrobiales, and a planctomycete ; primer 23R complemented 23s rRNA sequences from >50 known chlamydial strains and from a number of chloroplasts. Thus, the selection of these primers should reduce or eliminate mismatch amplification. Mg2+ concentration and K+ concentration in the reaction were kept moderate, to prevent EDTA and other compounds that might be added with the template from limiting amplification. When AmpliTaq DNA Gold DNA polymerase was used, amplification was quite specific for chlamydial template (Fig. 2) . However, when AmpliTag DNA polymerase was used, the chlamydial primers amplified most mycoplasma templates, even at elevated annealing temperatures (Fig. 2) . The improvement of specificity with AmpliTay Gold occurred because this enzyme is activated by a temperature-dependent increase in buffer pH as a first step in the amplification process (Perkin-Elmer technical bulletin 77 160 1-001, 1997). Enhanced specificity provided by Ampli Taq Gold made it possible to identify a small amount of C. tvachomatis L2/434/BU DNA in a sample of closely related Simkaniu template. Use of AmpliTaq Gold and a three-stage PCR amplification procedure enhanced the production of C. pneumoniae N16 PCR product against a background of mismatch-amplified M . hyorhinis product.
It was determined that the mycoplasmas amplified by the chlamydial primers in this study had one or more mismatches with the primers (Table 3 ). The apparent quantity of mismatch-produced amplicons was inversely related to the actual number of mismatches (especially 3' mismatches). Use of AmpliTaq Gold eliminated most of the mismatch amplification. It did not eliminate L. pneumophiZa amplification, however, because each primer had only a 1 base mismatch, according to 16s rRNA data in GenBank and partial sequence analysis of the L. pneumophila 23s rRNA gene. Whether a 2 base mismatch could prevent amplification when AmpliTaq Gold was used was not clear. However, the 3 base mismatch of the Simkania template with the 23R primer clearly prevented mismatch amplification by Ampli Taq Gold.
Mismatch amplification may prove useful for identifying new members of the order Chlamydiales. Primer 16SF2 matched the 16s rRNA from all four families in Chlamydiales; primer 23R perfectly complemented the 23s rRNA from Chlarnydiac*eae and Parachlarzzydiaceac' spp., had a 2 base mismatch with the Waddliaceae type species, and a 3 base mismatch with the Simkczniacecie type species. Thus, when AmpliTag DNA polymerase is used, these primers can be expected to generate an amplicon from the template of a culture of chlamydia-like bacteria. The relatedness of these bacteria to ChlumycliaceaP can be determined by direct sequence analysis of these amplicons. Previously, analyses of chlamydia-like isolates were hindered because these bacteria were not recognized by mAbs specific for the Chlamydiciccae. This work indicates that primers 16SF2 and 23R can aid in the discovery and characterization of new chlamydial families.
This PCR-RFLP identification method readily distinguished all nine proposed species of Chlamydiaceae and can be performed in most laboratories. Identifications may be confirmed by testing isolates with specific mAbs. Use of this method with AmpliTaq DNA polymerase contrasted with AmpliTaq Gold DNA polymerase discriminates between chlamydial isolates and mycoplasma contaminants. This assay may be useful in recognizing mixed cultures of chlamydiae and will help improve our understanding of chlamydial pathogenesis, taxonomy and epidemiology.
